Levetiracetam Tablet, Film Coated
Product Images NDC 50090-6086

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-6086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-of-levet1 (Figure Of Levet1)

Figure-of-levet1 (Figure Of Levet1)
A bar graph displaying the percentage of patients experiencing a certain outcome across three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The y-axis is labeled '% of Patients' ranging from 0% to 45%, indicating patient response rates for the respective treatments.*
FDA Label Image

Figure-of-levet2 (Figure Of Levet2)

Figure-of-levet2 (Figure Of Levet2)
A bar graph comparing the percentage of patients for three groups: Placebo (N=111) at 6.3%, Levetiracetam 1000 mg/day (N=106) at 20.8%, and Levetiracetam 2000 mg/day (N=105) at 35.2%. The y-axis is labeled '% of Patients' and ranges from 0% to 45%.*
FDA Label Image

Figure-of-levet3 (Figure Of Levet3)

Figure-of-levet3 (Figure Of Levet3)
A bar chart comparing the percentage of patients between two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%. The vertical axis shows the percentage of patients from 0% to 45%.*
FDA Label Image

Figure-of-levet4 (Figure Of Levet4)

Figure-of-levet4 (Figure Of Levet4)
A bar chart comparing the percentage of patients between Placebo (N=97) and Levetiracetam (N=101) groups. The vertical axis represents the percentage of patients, with Placebo showing 19.6% and Levetiracetam showing 44.6%. An asterisk is present over the Levetiracetam bar, indicating statistical significance.*
FDA Label Image

Figure-of-levet5 (Figure Of Levet5)

Figure-of-levet5 (Figure Of Levet5)
A bar chart comparing the percentage of patients in two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, ranging from 0% to 45%. The Placebo group shows 19.6% of patients, while the Levetiracetam group shows 43.1%. An asterisk is present above the Levetiracetam bar indicating a statistically significant difference.*
FDA Label Image

Figure-of-levet6 (Figure Of Levet6)

Figure-of-levet6 (Figure Of Levet6)
A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=84) shows 45.2% of patients, while the Levetiracetam group (N=79) shows 72.2%, with the y-axis labeled '% of Patients' ranging from 0% to 100%.*
FDA Label Image

Label Image (Lbl500906086)

Label Image (Lbl500906086)
Levetiracetam 1000 mg film-coated tablets label from A-S Medication Solutions. The label indicates the product is an oral tablet with 30 tablets per package. Storage instructions state to keep between 68 to 77 degrees Fahrenheit. The package includes a QR code and NDC 50090-6086-0.*
FDA Label Image

Levestructure (Levestructure)

Levestructure (Levestructure)
Chemical structure of Levetiracetam, showing its molecular arrangement with key functional groups including an ethyl group, a pyrrolidone ring, and amide features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.